Evidence map›Paper›PMID 10487823›Full record

ReviewThe American journal of pathology1999

Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?

M J Bissell

Abstract readCommentReview
In one paragraph

Review in The American journal of pathology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Tissue Engineering of the Microvasculature.Comprehensive Physiology · 2019
    Review
  7. Review
  8. Article
  9. Article
  10. Future options of anti-angiogenic cancer therapy.Chinese journal of cancer · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Brain tumor-targeted drug delivery strategies.Acta pharmaceutica Sinica. B · 2014
    Review
  16. Article
  17. Article
  18. Review
  19. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

M J BissellLife Sciences Division, Lawrence Berkeley National Laboratory, University of California, Berkeley, California, USA. MJBissell@lbl.gov

Funding

Role of Metalloproteinases in Mammary Gland RemodelingR01CA057621 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 1993 to 2017
$9.0M
Definition of the Microenvironment in Breast CancerR01CA064786 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 1995 to 2020
$6.1M
Definition of Microenvironment in Breast CancerR37CA064786 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 2009 to 2013
$2.0M
NCI NIH HHS CA57621NCI NIH HHS CA64786NCI NIH HHS R01 CA057621NCI NIH HHS R01 CA064786NCI NIH HHS R37 CA064786
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell DivisionEndothelium, VascularExtracellular MatrixHumansMelanomaMiceMicrocirculationNeoplasm InvasivenessNeovascularization, PathologicPhenotype

Identifiers

PMID10487823
PMCPMC1866900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.